Mary C Hooke1, Cheryl Rodgers, Olga Taylor, Kari M Koerner, Pauline Mitby, Ida Moore, Michael E Scheurer, Marilyn J Hockenberry, Wei Pan. 1. Author Affiliations: School of Nursing, University of Minnesota, Minneapolis (Dr Hooke); School of Nursing, Duke University, Durham, North Carolina (Drs Rodgers, Pan, and Hockenberry); Texas Children's Cancer and Hematology Centers/Baylor College of Medicine, Houston (Ms Taylor and Dr Scheurer); College of Nursing, University of Arizona, Tucson (Ms Koerner and Dr Moore); Children's Minnesota Cancer and Blood Disorders Program, Minneapolis (Ms Mitby and Dr Hooke).
Abstract
BACKGROUND: Children undergoing leukemia treatment report co-occurring symptoms of fatigue, sleep disturbances, pain, nausea, and depression as a symptom cluster. Physical activity (PA) is essential for development and may influence symptom severity. Children with leukemia are at risk of cognitive impairments from central nervous system therapies. Using a longitudinal parallel-process model, relationships among function and symptom clusters were explored. OBJECTIVE: This study examined the longitudinal mediation effects of PA on cognition via a symptom cluster during leukemia treatment. METHODS: Symptoms, PA, and cognitive function of 327 children aged 3 to 18 years were measured over 4 intervals during the first year of leukemia treatment. Children 7 years or older self-reported and parents reported for younger children. Parents completed cognitive function measurements for all children. The influence of the first time point and the subsequent change between all 4 time points of PA on the symptom cluster were explored. Analysis determined whether the symptom cluster mediated the effect of cognition over the treatment period. RESULTS: Patients with a higher PA at time 1 reduced their symptom cluster severity over the measurements. However, when PA increased over the measurements, symptom cluster severity also increased. When the symptom cluster was more severe at time 1, cognitive function was lower at time 1, and cognitive function decreased over time. When symptoms became more severe over time, cognitive function declined. CONCLUSIONS: The symptom cluster acted as a mediator between PA and cognition. IMPLICATIONS FOR PRACTICE: Symptom management during treatment may be an additional strategy for protecting cognitive function.
BACKGROUND:Children undergoing leukemia treatment report co-occurring symptoms of fatigue, sleep disturbances, pain, nausea, and depression as a symptom cluster. Physical activity (PA) is essential for development and may influence symptom severity. Children with leukemia are at risk of cognitive impairments from central nervous system therapies. Using a longitudinal parallel-process model, relationships among function and symptom clusters were explored. OBJECTIVE: This study examined the longitudinal mediation effects of PA on cognition via a symptom cluster during leukemia treatment. METHODS: Symptoms, PA, and cognitive function of 327 children aged 3 to 18 years were measured over 4 intervals during the first year of leukemia treatment. Children 7 years or older self-reported and parents reported for younger children. Parents completed cognitive function measurements for all children. The influence of the first time point and the subsequent change between all 4 time points of PA on the symptom cluster were explored. Analysis determined whether the symptom cluster mediated the effect of cognition over the treatment period. RESULTS:Patients with a higher PA at time 1 reduced their symptom cluster severity over the measurements. However, when PA increased over the measurements, symptom cluster severity also increased. When the symptom cluster was more severe at time 1, cognitive function was lower at time 1, and cognitive function decreased over time. When symptoms became more severe over time, cognitive function declined. CONCLUSIONS: The symptom cluster acted as a mediator between PA and cognition. IMPLICATIONS FOR PRACTICE: Symptom management during treatment may be an additional strategy for protecting cognitive function.
Authors: Tyler W Buckner; Jichuan Wang; Darren A DeWalt; Shana Jacobs; Bryce B Reeve; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2014-03-15 Impact factor: 3.167
Authors: Jin-Shei Lai; Frank Zelko; Zeeshan Butt; David Cella; Mark W Kieran; Kevin R Krull; Susan Magasi; Stewart Goldman Journal: Childs Nerv Syst Date: 2010-07-23 Impact factor: 1.475
Authors: Pamela S Hinds; Jie Yang; Jami S Gattuso; Marilyn Hockenberry; Heather Jones; Sue Zupanec; Chenghong Li; Valerie McLaughlin Crabtree; Belinda N Mandrell; Robert A Schoumacher; Kelly Vallance; Stacy Sanford; Deo Kumar Srivastava Journal: J Pain Symptom Manage Date: 2010-03 Impact factor: 3.612
Authors: Meaghann S Weaver; Jichuan Wang; Katie A Greenzang; Molly McFatrich; Pamela S Hinds Journal: Support Care Cancer Date: 2021-10-18 Impact factor: 3.603
Authors: Mary C Hooke; Daniel Hatch; Marilyn J Hockenberry; Susan Whitman; Ida Moore; David Montgomery; Kari Marano; Pauline Mitby; Michael E Scheurer; Olga Taylor; Wei Pan Journal: J Pediatr Oncol Nurs Date: 2020-03-06 Impact factor: 1.636
Authors: Amanda Wurz; Emma McLaughlin; Carolina Chamorro Viña; Sarah L Grimshaw; Lotta Hamari; Miriam Götte; Sabine Kesting; Francesca Rossi; Patrick van der Torre; Gregory M T Guilcher; Krista McIntyre; S Nicole Culos-Reed Journal: Curr Oncol Date: 2021-01-20 Impact factor: 3.677
Authors: Liwen Peng; Lok Sum Yang; Perri Yam; Chun Sing Lam; Agnes Sui-Yin Chan; Chi Kong Li; Yin Ting Cheung Journal: Front Oncol Date: 2021-04-20 Impact factor: 6.244
Authors: Pamela S Hinds; Meaghann S Weaver; Janice S Withycombe; Justin N Baker; Shana S Jacobs; Jennifer W Mack; Scott H Maurer; Molly McFatrich; Laura C Pinheiro; Bryce B Reeve; Jichuan Wang Journal: J Pain Symptom Manage Date: 2020-10-20 Impact factor: 5.576
Authors: Amanda Wurz; Emma McLaughlin; Conné Lategan; Carolina Chamorro Viña; Sarah L Grimshaw; Lotta Hamari; Miriam Götte; Sabine Kesting; Francesca Rossi; Patrick van der Torre; Gregory M T Guilcher; Krista McIntyre; S Nicole Culos-Reed Journal: Transl Behav Med Date: 2021-10-23 Impact factor: 3.046